Sarcomas are cancers of mesenchymal origin with the potential to arise in diverse anatomic locations. With over 80 subtypes, which often demonstrate overlapping morphologies, sarcomas often require ancillary testing to enable accurate classification. Pathognomonic driver mutations can often be leveraged for diagnostic purposes, and include fusion genes, amplification events and recurrent point mutations.